Picon Hector, Guddati Achuta Kumar
Medical College of Georgia, Augusta University Augusta 30909, GA, USA.
Division of Hematology/Oncology, Georgia Cancer Center, Augusta University Augusta 30912, GA, USA.
Am J Stem Cells. 2021 Aug 15;10(3):28-35. eCollection 2021.
Cancer stem cells (CSCs) are a unique population of cells found within tumors that are able to self-renew, restore the original heterogeneity of a tumor following treatment, and show increased tumorigenic potential when compared to other cancer cells. It is thought that they are responsible for the recurrence of tumors as well as the resistance to treatment that is seen clinically. CSCs are known to be involved in head and neck cancer (HNCs) specifically, as evidence for their existence can be found in head and neck squamous cell carcinoma (HNSCC), mucoepidermoid carcinoma (MEC), and adenoid cystic carcinoma (ACC), among others. Here, findings from various approaches to identifying and targeting CSCs and their downstream effectors in HNC are summarized, with an emphasis on recent advancements. Prognostic and therapeutic markers are discussed for each specific type of HNC, and novel treatment strategies and current clinical trials involving CSCs are detailed as well. The information provided here is intended to further the research on this important topic and lead to clinical impact in the battle against HNC.
癌症干细胞(CSCs)是肿瘤内发现的一类独特细胞群,它们能够自我更新,在治疗后恢复肿瘤原有的异质性,并且与其他癌细胞相比具有更高的致瘤潜力。人们认为它们是肿瘤复发以及临床上所见治疗抗性的原因。已知CSCs特别涉及头颈癌(HNCs),因为在头颈部鳞状细胞癌(HNSCC)、黏液表皮样癌(MEC)和腺样囊性癌(ACC)等疾病中都能找到它们存在的证据。在此,总结了在HNC中识别和靶向CSCs及其下游效应器的各种方法的研究结果,重点是近期进展。针对每种特定类型的HNC讨论了预后和治疗标志物,还详细介绍了涉及CSCs的新型治疗策略和当前临床试验。此处提供的信息旨在推动对这一重要课题的研究,并在对抗HNC的斗争中产生临床影响。